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ABSTRACT
Urticaria occurs commonly in children and young adults. In 
general, a younger and atopic population is usually involved 
and the lesions are acute, usually less than 6 weeks in dura-
tion and it is relatively easy to show a cause and effect, usu-
ally by history. The cause of chronic urticaria, which is 
defined as urticaria lasting longer than 6 weeks, is much 
more difficult to identify and 80-95% of patients are classi-
fied as idiopathic. Many of the patients react with a wheal 
and flare to their own serum or plasma indicating that they 
have a histamine-releasing agent in their own serum. Most 
of these subjects will have urticaria which clears with time but 
a small minority continue to have urticaria for the rest of their 
lives. 
 Treatment for patients having known causes is to avoid the 
triggers and all patients with chronic urticaria need to be 
treated with H1 antihistamines. Sometimes an H2 antihista-
mine is added or a tricyclic'tranquilizer' which has anti Hl 
and H2 blocking action needs to be used. Those patients 
who do not respond may need treatment with prednisone 
which should be reduced to the smallest dosage and dis-
continued as soon as possible. Patients with hereditary 
angioedema respond to danazol, stanozol or epislan-
aminocaproic acid or tranexamic acid.
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INTRODUCTION
Urticaria is a transient eruption characterized by circumscribed 
erythematous swelling in the skin. The lesions result from 
vasodilation of small venules and capillaries, and exudation of 
fluid into the superficial dermis.1 Angioedema is caused by a 
similar mechanism occurring in the deep dermis and subcuta-
neous tissues and is usually less pruritic and less well circum-
scribed. Urticaria (hives) usually occur on the trunk and 
proximal extremities while angioedema characteristically affects
the face, hands, feet and genitalia. Involvement of the airways 
suggests C1 inhibitor-associated forms of angioedema. The most 
frequent type of acute urticaria and angioedema involves a 
period of less than 6 weeks in duration and occurs commonly in 
children and young adults. In general, a younger and atopic 
population is usually involved. Chronic urticaria, which lasts 
greater than 6 weeks in duration, peaks most commonly between 
the ages of 40 and 60, although children are also affected. 
Women are affected more commonly than men. In most studies, 
a specific cause is identified in less than 10% of cases. 
  Figure 1 summarizes the topics discussed in this review 
and shows the stepwise consideration of the causes of hives 
and angioedema followed by their diagnostic procedures and 
treatment.2
PATHOGENESIS
The mast cell is critical to the pathogenesis process. The char-
acteristic wheal and flare was produced in normal skin by Sir 
Thomas Lewis in 1927 by the intracutaneous injection of hista-
mine. Mast cells can be induced to release histamine and other 
inflammatory mediators by a variety of processes. These include 
non-immunologic, immunologic and genetic factors. 
 Non-immunologic factors include: (i) chemical histamine lib-
erators such as opiates, curare and polymyxin B; (ii) direct 
effects of physical agents; (iii) cholinergic effects via heat or 
increased blood supply to the skin and defects of the non-
adrenergic non-cholinergic system. Immunologic factors com-
plement activation by the classic or alternative pathways, 
anaphylatoxins (C3a and C5a) and IgE mediated allergy. 
Genetic factors include a deficiency in various complement fac-
tors and modulating factors, including hormones, autoantibod-
ies and aggravating influences. 
  Figure 2 is a diagrammatic representation of the interactions 
that cause a wheal and flare, including the release of histamine 
and of substance P. Antigen or IgE antibody cross-links several 
receptors on the surface of the mast cell. This cell then releases 
a variety of factors including pre-formed and newly formed fac-
tors. In addition, afferent cutaneous nerves will release such 
neurogenic factors as substance P which has a direct effect on 
the blood vessels. These are active factors which are potential 
mediators of urticaria and angioedema. The sources of these
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Fig. 1 Causes, diagnostic procedures 
and treatment of hives and angioedema. 
Reproduced with permission from 
Hobbs KF and Schocket A. Urficaria 
and angioedema. In: Bierman CW, 
Pearlman DS, Shapiro GG, Busse WW, 
eds. Allergy, Asthma, and Immunology 
from Infancy to Adulthood. 3rd edn. WB 
Saunders, Philadelphia, 1995.
active agents are cutaneous mast cells which release histamine, 
prostaglandin D2, leukotrienes C and D, platelet-activating fac-
tor and the kallikrein-like enzyme, bradykinin. The complement 
system releases anaphylatoxins C3a, C4a, C5a and histamine. 
The Hageman factor-dependent pathway release bradykinin 
and mononuclear cells release a variety of histamine-releasing 
factors.3 
 Increased vascular permeability leads to activation of the 
plasma kinin system and Hageman factor activation with forma-
tion of bradykinin. The interplay of mononuclear cell T and B 
lymphocytes and monocytes release histamine and other 
vasoactive factors from basophils and mast cells.4 Histamine 
causes vascular permeability, edema, vasodilation and ery-
thema (increased blood supply) causing a flare in the skin. 
Histologically one sees the dilation of small vessels, widened 
dermal papillae, flattened reti pegs, separation of collagen 
bundles and lesions occurring in the superficial dermis.5
 Figure 3 shows the epidemiology of hives. The incidence rate 
increases from 3.5 per 100000 individuals at age 5 years to 12 
per 100 000 by 20-40 years of age. Hive incidence then 
decreases steadily to 2 per 100000 by age 70 years.6 
  Figure 4 shows the average duration of urticaria. Half of 
those with urticaria will clear in 1 year and three-quarters 
will clear in 5 years. By 10 years one-fifth of the subjects 
with c ronic urticaria will still have problems which may be 
ongoing.' 
 The overall known causes of acute and chronic urticaria are 
rugs, foods, food additives, inhalant, ingestant or contact 
allerge s, a variety of parasitic, bacterial and fungal infections, 
i sect stings, urticaria pigmentosa or systemic mastocytosis, 
autoimmune diseases, malignancies, endocrine diseases, her-
editary diseases, transfusion reactions, physical urticaria, and 
autoimmune conditions. However, the cause of chronic urti-
caria is unknown in 80-95% of patients.
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Fig. 2 Diagrammatic representation of interactions causing a wheal 
and flare in acute and chronic urticaria. Reproduced from Kaplan AP. 
Acute and chronic urticarias. Insights in Allergy 1989, (4) 3 with permis-
sion by The CV Mosby Co.
Fig. 3 Epidemiology of hives: Incidence at various ages. Reproduced 
with permission from Blackwell Scientific Publications Ltd. (Ref. 7).
Drugs 
Penicillins are the most common and best studied cause of 
urticaria from drugs.8 Chemotherapeutic sulfonamides and 
other agents of that group, including sulfonylurea oral hypo-
glycemia agents, thiazide diuretics, furosemide, carbonic anhy-
drase inhibitors and procaine-type local anesthetics have been 
known to cause urticaria. Aspirin and other non-steroidal anti-
inflammatory drugs (NSAID), radiocontrast dyes and other sub-
stances can also induce urticaria.9
Foods and food additives 
Among the foods responsible for causing reactions (IgE medi-
ated) are shell fish, fish, eggs, peanuts, nuts and fruits in adults,
Fig. 4 Epidemiology of acute and chronic urticaria: Length of urticarial 
manifestations. Reproduced with permission from Blackwell Scientific 
Publications Ltd. (Ref. 7).
and eggs, milk and peanuts in children.10 Food additives are 
probably not IgE mediated and they include tartrazine, sulfites, 
benzoates and, perhaps, natural salicylates.11 And finally, 
inhalant and contactant allergens may be IgE mediated. All the 
usual inhalant allergens are capable of inducing urticaria via 
IgE pathways.
Infections 
In the infectious category are viral infections such as infectious 
hepatitis, infectious mononucleosis and a variety of others. In 
some patients there is a possible relationship to group A Beta 
streptococcal infections and urticaria. Fungal infections and 
parasitic infections such as ascaris, ancylostoma, strongyloides, 
filaria, echinococcus, schistosoma, trichinella, toxocara and 
fasciola also have been implicated but rarely cause urticaria 
even in endemic areas.
Insects 
Insect bites and stings can cause urticaria. The most prominent 
among them are hymenoptera stings from wasps, yellow jack-
t , hornets, bees and fire ants. Popular urticaria results from 
flea bites, swimmer's itch and possibly mosquito bites, and may 
be confused with hives. However, if one outlines a lesion with 
ink, th  lesion will be present for several days which is not char-
acteris ic of urticaria which remains for only a few hours and 
then moves on to other sites.
Other causes 
Urticaria pigmentosa and systemic mastocytosis will result in 
pigmented nevi over the bodies of children. When they are 
rubbed they urticate because histamine is released from skin
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mast cells. Autoimmune diseases including systemic lupus ery-
thematosus, serum sickness, cutaneous vasculitis, Sjogren's 
Syndrome and rheumatoid arthritis are autoimmune diseases, 
which may have urticaria as symptoms. Fortunately they are all 
associated with an elevated sedimentation rate which is a defi-
nite factor in diagnosis. Malignancies rarely induce urticaria. 
Those that do are lymphoma and Hodgkin's disease. Endocrine 
diseases both hyper and hypothyroidism and hyperparathy-
roidism can result in urticaria. Estrogen in some patients can 
cause urticaria.12,13
Hereditary disease
Hereditary urticaria includes hereditary C1 inhibitor deficiency 
angioedema.14 Clinically, one has recurrent attacks of angio-
edema with laryngeal and gastrointestinal involvement which 
do not respond to epinephrine. On laboratory examination the 
C1 inhibitor is low in 85% of cases and may be normal or ele-
vated but non-functional in 15% of cases. The C4 is lower dur-
ing attacks and but less depressed between attacks. C1 
deficiency levels in acquired angioedema are low but are nor-
mal in the hereditary disease; C1 q binding is elevated in the 
acquired but normal in the hereditary disease. The hereditary 
type is an autosomal dominant disease. The acquired type 
that occurs with malignancy, lymphoma and carcinoma also 
occurs with auto-antibodies to the C1 inhibitor which render it 
non-functional. 
  Hereditary vibratory angioedema is a very rare autosomal 
dominant disease. C3b inactivator deficiency is thought to be 
an autosomal recessive disease. Familial urticaria with amyl-
oidosis and deafness is very rare and is a dominant disease.
Physical urticarias
Physical urticaria includes idiopathic cold urticaria with a devel-
opment of hives at local sites of cold contact. Occasionally it is 
IgE mediated and can be transferred by serum to another subject 
by injecting it intradermally. It is confirmed by placing an ice cube 
on the skin of the patient for 5 min. There is also a cold urticaria 
associated with cold agglutinins, cryoglobulins and cryofibrino-
gen.15 Cholinergic urticaria is associated with small, punctate 
wheals with large flares induced by exercise, sweating, anxiety or 
hot showers. It may be associated with a fall in lung function. 
Exercise-induced anaphylaxis is precipitated by exercise and 
sometimes associated with foods such as celery but it is often 
associated with eating. It occurs 5-30 min after exercise and it 
may last between 1 and 3h. It may be associated with a spec-
trum of anaphylactic symptoms and pulmonary function does 
not fall, and it is not associated with the heating of the body. 
  Symptomatic dermatographism is present in a small number 
of the 2-5% of the general population that has dermato-
graphism. It is precipitated by gentle stroking of the skin which 
results in a large wheal and flare within approximately 5 min. In 
some people there has been a transferable factor identified.
Oth r forms of physical urticaria include delayed pressure 
urticaria, heat urticaria, aquagenic urticaria, solar urticaria and 
vibratory angioedema. 
Chronic idiopathic urticaria occurs in 80-95% of individuals 
with chronic urticaria. The patients do not have atopic diseases 
as IgE levels are frequently normal but not always. Urticaria can 
be mild or severe. On biopsy, one sees a non-necrotizing 
perivascular infiltrate, a ten-fold increase in the number of mast 
cells and a four-fold increase in the number of mononuclear 
cells. Activated CD4 helper T cells are also increased and there 
may be increased depositions of eosinophil basic protein in skin 
lesions. 16
EVALUATION
In t e evaluation of patients with chronic urticaria a history is 
important. One should inquire about the time of onset and 
wh ther it occurred abruptly or insidiously, the frequency of the 
ruption, possible triggers and the family prevalence of 
urticaria. On physical examination one should look at the skin 
lesions, possibly outlining them in ink, and should examine for 
sig s of atopy such as nasal congestion or wheezing. A painful 
anterior neck suggests thyroiditis; nodes enlarged over the body 
suggest such factors as infectious mononucleosis, lymphoma or 
Hodgkin's disease. Beta-hemolytic symptoms are evidenced by 
a r d hroat with enlarged glands in the neck only. One should 
also examine for arthritis, edema which suggests kidney 
dise se, and examine the eyes for the dryness of Sjogren's 
syndrome. 
 The laboratory tests are selected on the basis of the history 
nd physical examination. In atopic patients, prick tests may be 
required for foods, or prick and intradermal tests for inhalant 
factors. A complete blood count and differential and sedimen-
tation rate should be determined in patients with chronic 
urticaria. While with the patient, gentle stroking of the skin will 
reveal dermatographism 5-15 min later. Direct exposure to an 
ice cube for 5 min will reveal cold-induced urticaria. If one sus-
pects cholinergic urticaria the injection of 100ug of metha-
choline directly into the skin will produce a wheal and flare. The 
differential between heat-induced and exercise-induced ana-
phylaxis can be identified by doing an exercise test for 10 min at 
80% of cardiac output in a plastic rain suit. A fall in lung func-
tion with small punctate hives suggests cholinergic urticaria 
while signs of anaphylaxis without change in lung function sug-
gests exercise-induced anaphylaxis.
TREATMENT
The treatment of urticaria involves avoidance of physical stimuli, 
drugs, if they are the cause, food and additives which induce 
hives, and also avoidance of modulating factors such as emo-
tions, exertion and alcohol. Prescribing antihistamines with 
cyproheptadine is recommended in the US for cold urticaria, 
but ketotifen (not available in the US but available in Japan)
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seems to be a very effective agent for its prevention. Other anti-
histamines include astemizole,17 terfenadine and hydroxyzine.'8 
Antihistamine drugs should be taken regularly and not on an 'as 
needed' basis. Cholinergic urticaria or symptomatic dermato-
graphism is treated with hydroxyzine or cetirizine. Cetirizine is
not as sedating as hydroxyzine and is formed when hydroxyzine 
is metabolized in the liver. The second generation antihista-
mines have been used for other forms of urticaria. Epinephrine 
may be administered subcutaneously for acute swelling of 
the throat or mouth, but will have no effect on hereditary 
angioedema.
 Cimetidine or ranitidine (H2 blockers) have been used com-
bined with Hl antihistamine when Hl blockers by themselves 
are ineffective. Tricyclic compounds such as doxepin which have 
an H1 and H2 blocking action have also been prescribed. In 
the cases where the antihistamines fail to work, oral cortico-
steroids are prescribed. Once improvement occurs the dosage 
may be tapered to the smallest effective amount and then 
administered every other day. The dose is then gradually 
reduced until the steroid can be discontinued. In hereditary or 
acquired angioedema, anabolic synthetic steroids such as
danazol or stanozolol have been used and seem to be effective 
in preventing further attacks in some patients, as is epsilon-
aminocaproic acid and tranexamic acid. Swelling of the larynx 
may necessitate a tracheotomy.
In summary, most of the cases of urticaria occur without a
known cause and a major goal of therapy is symptom relief. The
primary drugs are H1 and, possibly, the H2 antihistamines. The
antihistamines must be used regularly and not as needed.
Steroids should be added if the subject breaks through antihist-
amine therapy. Reduce the steroids to the smallest possible dose 
and then give every other day, finally discontinuing the steroids 
as soon as possible.
DISCUSSION
Hide et al. described 20 patients in a group of 25 who reacted 
to their own serum or plasma with a wheal and flare when it was 
injected intradermally.19 They read the histamine reaction at half
an hour and the intradermal serum reaction at 1 hour. These 
patients had low IgE levels in their blood. Further in vitro tests 
showed that the reaction could be blocked by adding IgE to the 
serum or removing IgE. They also noted that these patients with
a positive skin test to their own serum had lower levels of IgE 
than those who did not. Accordingly, they hypothesized that it 
was due to an IgG in the patients' serum which was directed 
against the high affinity IgE receptor.
 We did a similar study where the study group consisted of 8 
males and 17 females with chronic urticaria.20 There was one 
child under 12 years of age, four patients who were adolescent 
between 13 and 18 years and 20 adults. The adults ranged in 
age from 19 to 63 years. Eleven patients had either hay fever 
or asthma as well as chronic urticaria, three had symptomatic
Table 1. Patient response to their own serum or plasma
dermatographism and 11 patients had idiopathic urticaria. IgE 
levels were done on these patients. The mean level of the atopic
patients was 171.25±80.45IU (±SD) not including the one
patient who had an IgE level of 1490 IU. The level in the der-
matographism patients was 13IU. Those with idiopathic urti-
caria had an average level of 55.0±46IU (±SD). Each of
these patients was skin tested with 5μmL of autologous serum
or plasma which was read at 15 min and 1h, and with hista-
mine in the concentration of 275μg/mL which was read in half
hour intervals. A wheal measuring 5mm or greater than the 
saline control was considered a positive reaction. There was a 
statistically significant difference in IgE levels between those who 
were atopic and those with only idiopathic urticaria. All patients
reacted to control histamine injection proving that they had not 
taken anything that would interfere with a positive skin test when 
tested with 0.02mL of autologous serum. The results are shown 
in Table 1.
 Patients who have a positive skin test to their own serum or 
plasma have a histamine releasing factor in their serum. It is not 
yet known what this factor is. However, we can predict that these 
patients will be harder to treat than those with negative tests. 
Few of the patients in our study had the low IgE levels noted by
Hide et al. Indeed most of those with negative skin tests 
responded to H1 antihistamines, while some of those with posi-
tive skin tests frequently required a drug with H2 blocking action 
or a systemic corticosteroid in their early therapy.
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